...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: RVXOT
3
May 05, 2020 06:31PM
2
May 05, 2020 09:01PM
1
May 06, 2020 09:21AM
1
May 06, 2020 11:02AM

No, I attempted to point out the Zenith stock listing on the Venture Exchange.

The stock ZENI-P-X description speels out ZEN-3694.

Zenith Capital Corp. (Instrument ExchangeTSX Venture: Instrument Symbol ZENI-P-X)

This cannot be so.

Koo

1
May 06, 2020 11:59AM
1
May 06, 2020 01:36PM
1
May 06, 2020 02:32PM
Share
New Message
Please login to post a reply